Division of Hematology and Oncology, Taipei Veterans General Hospital

Taipei 112

0 studies enrolling now · 1 studies all time

What they study most

Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)

Studies at this site

• A Study of Atezolizumab (Anti-PD-L1 Antibody) as Adjuvant Therapy After Definitive Local Therapy in Patients With High-Risk Locally Advanced Squamous Cell Carcinoma of the Head and Neck — Stopped early